Fingolimod Settlement Agreement Begets New Disagreements 21 Mar 2022Marcus Klee, Rob Youngson In March 2019, Novartis and Pharmascience entered into a settlement agreement giving Pharmascience a non-exhaustive license to sell its generic version of... Read More